4DMedical Limited (4DX.AX)
AUD 0.25
(0.0%)
AUD 0.25
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -36.06 Million AUD | 5.59% |
| 2023 | -33.74 Million AUD | 18.98% |
| 2022 | -36.34 Million AUD | -95.47% |
| 2021 | -18.03 Million AUD | -17.29% |
| 2020 | -15.76 Million AUD | -122.42% |
| 2019 | -6.73 Million AUD | -38.02% |
| 2018 | -4.35 Million AUD | -10.04% |
| 2017 | -4.55 Million AUD | -442.67% |
| 2016 | -838.88 Thousand AUD | -350.38% |
| 2015 | -186.26 Thousand AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 FY | - AUD | -54.59% |
| 2024 Q1 | -11.27 Million AUD | 31.4% |
| 2024 Q4 | -11.09 Million AUD | 0.0% |
| 2024 Q2 | -22.03 Million AUD | -48.5% |
| 2024 Q3 | -11.09 Million AUD | 33.76% |
| 2023 Q3 | -10.51 Million AUD | 50.03% |
| 2023 FY | - AUD | 18.98% |
| 2023 Q1 | -10.52 Million AUD | 43.79% |
| 2023 Q4 | -20.96 Million AUD | -99.35% |
| 2023 Q2 | -21.04 Million AUD | -100.0% |
| 2022 Q1 | -8.26 Million AUD | 32.5% |
| 2022 Q2 | -16.53 Million AUD | -100.0% |
| 2022 Q4 | -18.71 Million AUD | -92.91% |
| 2022 FY | - AUD | -95.47% |
| 2022 Q3 | -9.7 Million AUD | 41.32% |
| 2021 Q3 | -6.3 Million AUD | 44.42% |
| 2021 FY | - AUD | -17.29% |
| 2021 Q2 | -11.34 Million AUD | -100.0% |
| 2021 Q1 | -5.67 Million AUD | 43.22% |
| 2021 Q4 | -12.24 Million AUD | -94.19% |
| 2020 Q1 | -2.53 Million AUD | -25.48% |
| 2020 Q3 | -5.25 Million AUD | -3.48% |
| 2020 Q4 | -9.99 Million AUD | -90.26% |
| 2020 FY | - AUD | -122.42% |
| 2020 Q2 | -5.07 Million AUD | -100.0% |
| 2019 Q4 | -2.02 Million AUD | 0.0% |
| 2019 Q2 | -1.43 Million AUD | 0.0% |
| 2019 Q1 | -1.43 Million AUD | 0.0% |
| 2019 FY | - AUD | -38.02% |
| 2019 Q3 | -2.02 Million AUD | -41.01% |
| 2018 FY | - AUD | -10.04% |
| 2017 FY | - AUD | -442.67% |
| 2016 FY | - AUD | -350.38% |
| 2015 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Adherium Limited | -11.56 Million AUD | -211.876% |
| Aroa Biosurgery Limited | -7.36 Million AUD | -390.032% |
| Atomo Diagnostics Limited | -5.42 Million AUD | -565.01% |
| Anteris Technologies Ltd | -66.9 Million AUD | 46.092% |
| Control Bionics Limited | -5.15 Million AUD | -599.211% |
| CardieX Limited | -6.71 Million AUD | -437.36% |
| Compumedics Limited | 2.78 Million AUD | 1393.179% |
| Cochlear Limited | 579.5 Million AUD | 106.224% |
| CleanSpace Holdings Limited | -3.49 Million AUD | -932.897% |
| Cyclopharm Limited | -3.03 Million AUD | -1088.4% |
| EMVision Medical Devices Ltd | -2.09 Million AUD | -1624.685% |
| Nova Eye Medical Limited | -5.97 Million AUD | -503.224% |
| HeraMED Limited | -3.97 Million AUD | -808.011% |
| Imricor Medical Systems, Inc. | -21.87 Million AUD | -64.911% |
| ImpediMed Limited | -22.05 Million AUD | -63.561% |
| InhaleRx Limited | -1.41 Million AUD | -2451.153% |
| LBT Innovations Limited | -4.04 Million AUD | -790.757% |
| Micro-X Limited | -14.35 Million AUD | -151.319% |
| Neurotech International Limited | -8.24 Million AUD | -337.489% |
| OncoSil Medical Limited | -11.97 Million AUD | -201.154% |
| PolyNovo Limited | 5.17 Million AUD | 797.616% |
| Respiri Limited | -7.04 Million AUD | -411.592% |
| SomnoMed Limited | -2.32 Million AUD | -1448.851% |
| Universal Biosensors, Inc. | -9.09 Million AUD | -296.755% |
| Uscom Limited | -1.5 Million AUD | -2289.619% |
| Visioneering Technologies, Inc. | -4.91 Million AUD | -633.453% |